Lv31
220 积分 2023-06-01 加入
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
1小时前
已完结
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2
1个月前
已完结
CDK4/6 inhibitors in breast cancer: spotting the difference
1个月前
已完结
Monitoring APOBEC3A protein levels in human cancer cells
3个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
5个月前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
6个月前
已完结
AXL activates YAP through the EGFR–LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma
6个月前
已完结
Exploring the next generation of antibody–drug conjugates
6个月前
已完结
The antibody-drug conjugate landscape
6个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
6个月前
已完结
H 2 ‐Directing Strategy on In Situ Synthesis of Co‐MoS 2 with Highly Expanded Interlayer for Elegant HER Activity and its Mechanism
皖公网安备34019202002308
